Personalizing Therapy for Patients With CML

Michael J. Mauro, MD

Video Categories: CML

Dr. Mauro addresses the debate over selecting first line therapy with three approved agents available.
November 19, 2014

Costs of Treatment in Polycythemia Vera

Ken Schaecher, MD, presents his own personal opinion on the challenges of concerns related to costs of treatment by oncologists and why they should not ignore them. Supported through funding from Incyte

November 24, 2014

Is Research Translating to Meaningful Treatment to Patients?

Dr. Palmer describes how the direct relationship between treatment directed to change in the DNA actually affects the outcome of patients.